Cargando…

Sex Differences in the Impact of Metabolic Dysfunction-associated Fatty Liver Disease on the of Patients with Hepatocellular Carcinoma After Radical Resection

Background: International experts have put forward a new definition for metabolic dysfunction-associated fatty liver disease (MAFLD). Nonetheless, sex differences in MAFLD function in hepatocellular carcinoma (HCC) survival is still unknown. Therefore, the current work focused on exploring the gende...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Junzhang, Wei, Suosu, Tang, Yuntian, Zhang, Qiuhuan, Luo, Honglin, Tang, Zhenyong, Tang, Yi, Liu, Hongjun, Huang, Wei, Dong, Xiaofeng, Yang, Jianrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197934/ https://www.ncbi.nlm.nih.gov/pubmed/37215444 http://dx.doi.org/10.7150/jca.83779

Ejemplares similares

The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer
por: Wei, Suosu, et al.
Publicado: (2023)

The Role of Metabolic Dysfunction–Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study
por: Wei, Suosu, et al.
Publicado: (2023)

MicroRNA-7-5p Inhibits Migration, Invasion and Metastasis of Intrahepatic Cholangiocarcinoma by Inhibiting MyD88
por: Tang, Yi, et al.
Publicado: (2021)

Correlation of DEPDC5 rs1012068 and rs5998152 Polymorphisms with Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Zhu, Shaoliang, et al.
Publicado: (2023)

The relationship between women’s body mass index and breast cancer outcomes was U-shaped
por: Wei, Wensong, et al.
Publicado: (2023)

Age has a U-shaped relationship with breast cancer outcomes in women: a cohort study
por: Xie, Yujie, et al.
Publicado: (2023)

CDK2 positively regulates aerobic glycolysis by suppressing SIRT5 in gastric cancer
por: Tang, Zhenyong, et al.
Publicado: (2018)

Predictive potential of Nomogram based on GMWG for patients with hepatocellular carcinoma after radical resection
por: Ren, Liying, et al.
Publicado: (2021)

Liver Resection for Hepatocellular Carcinoma in Patients with Renal Dysfunction
por: Shirata, Chikara, et al.
Publicado: (2018)

The Gene Signature Associated with Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
por: Ge, Jiayun, et al.
Publicado: (2021)

Radical resection and reconstruction of the sternum for metastasis of hepatocellular carcinoma
por: Yoon, Young Chul, et al.
Publicado: (2020)

Sex-Specific Contribution of Cardiometabolic Index in Predicting Metabolic Dysfunction-Associated Fatty Liver Disease: Insights from a General Population
por: Gu, Dongxing, et al.
Publicado: (2023)

Prognostic Value of Surgical Site Infection in Patients After Radical Colorectal Cancer Resection
por: Tang, Yu, et al.
Publicado: (2020)

How to establishing an indicators framework for evaluating the performances in primary TB control institutions under the new TB control model? Based on a Delphi study conducted in Guangxi, China
por: Wu, Tengyan, et al.
Publicado: (2022)

Nomograms to predict the long‐time prognosis in patients with alpha‐fetoprotein negative hepatocellular carcinoma following radical resection
por: Huang, Jian, et al.
Publicado: (2020)

Quantitative proteomics analysis of early recurrence/metastasis of huge hepatocellular carcinoma following radical resection
por: Huang, Xinhui, et al.
Publicado: (2014)

Comment on “Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis”
por: Tang, Xiao-Long, et al.
Publicado: (2022)

Caudate lobe as the sole remnant liver following extended liver resection for hepatocellular carcinoma
por: Aijun, Li, et al.
Publicado: (2014)

Rs4938723 Polymorphism Is Associated with Susceptibility to Hepatocellular Carcinoma Risk and Is a Protective Factor in Leukemia, Colorectal, and Esophageal Cancer
por: Xu, Bin, et al.
Publicado: (2018)

Clinical and Molecular-Based Approach in the Evaluation of Hepatocellular Carcinoma Recurrence after Radical Liver Resection
por: Gruttadauria, Salvatore, et al.
Publicado: (2021)

Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
por: Song, Byeong Geun, et al.
Publicado: (2023)

Local resection versus radical resection after neoadjuvant chemoradiotherapy for patients with locally advanced rectal cancer: a propensity-score matched cohort analysis
por: Wang, Guancong, et al.
Publicado: (2023)

A Case of Curative Treatment with Apatinib and Camrelizumab Following Liver Resection for Advanced Hepatocellular Carcinoma
por: Huang, Julu, et al.
Publicado: (2023)

Clinical Study on the Efficacy of Laparoscopic Hepatectomy and Its Influence on the Expression of Serum VEGF, FGF, and Immune Function
por: Tang, Zhengyong, et al.
Publicado: (2021)

Novel Ferrocene Derivatives Induce G0/G1 Cell Cycle Arrest and Apoptosis through the Mitochondrial Pathway in Human Hepatocellular Carcinoma
por: Zheng, Jianrong, et al.
Publicado: (2021)

Effect of menopausal status on the survival and recurrence of sex-classified hepatocellular carcinoma after liver resection: a case-matched study with propensity score matching
por: Zhang, Wenli, et al.
Publicado: (2020)

Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progression
por: He, Michelle Junyi, et al.
Publicado: (2022)

Perirenal Fat Thickness is Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes Mellitus
por: Yang, Jian, et al.
Publicado: (2023)

Prognostic Analysis of Single Large Hepatocellular Carcinoma Following Radical Resection: A Single-Center Study
por: Huang, Jian, et al.
Publicado: (2023)

Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection
por: Cai, Xiao-Yan, et al.
Publicado: (2016)

The serum proteomics tracking of hepatocellular carcinoma early recurrence following radical resection
por: Liu, Hongzhi, et al.
Publicado: (2019)

PAMAM-Lys, a Novel Vaccine Delivery Vector, Enhances the Protective Effects of the SjC23 DNA Vaccine against Schistosoma japonicum Infection
por: Wang, Xiaoting, et al.
Publicado: (2014)

Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact
por: Tang, Si-Ying, et al.
Publicado: (2023)

Nomogram to predict postoperative cognitive dysfunction in elderly patients undergoing gastrointestinal tumor resection
por: Huang, Huifan, et al.
Publicado: (2022)

Prognostic Factors for Patients with Proliferative Hepatocellular Carcinoma After Liver Resection
por: Li, Hong-Mei, et al.
Publicado: (2023)

Outcomes of neoadjuvant chemoradiotherapy followed by radical resection for T4 colorectal cancer
por: Huang, Chun-Ming, et al.
Publicado: (2020)

Efficacy and safety of laparoscopic radical resection following neoadjuvant therapy for pancreatic ductal adenocarcinoma: A retrospective study
por: He, Yong-Gang, et al.
Publicado: (2022)

Liver resection for early hepatocellular cancer: Comparison of centers in 3 different countries
por: Wong, Linda L, et al.
Publicado: (2016)

Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report
por: Liao, Rui, et al.
Publicado: (2015)

A Consensus Meeting on Expert Recommendations on Operating Specifications for Laparoscopic Radical Resection of Hilar Cholangiocarcinoma
por: Xiong, Yongfu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k7imbo0sab5u8fnpq394r1hf5f